Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma.

Autor: Sabe, Hideaki¹ (AUTHOR), Inoue, Akitomo¹ (AUTHOR), Nagata, Shigenori² (AUTHOR), Imura, Yoshinori¹ (AUTHOR), Wakamatsu, Toru¹ (AUTHOR), Takenaka, Satoshi¹ (AUTHOR), Tamiya, Hironari^1,3 (AUTHOR)

Publikováno v: Case Reports in Oncological Medicine. 6/17/2021, p1-6. 6p.

Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition.

Autor: Mae H; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Outani H; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Imura Y; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Chijimatsu R; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan., Inoue A; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Kotani Y; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Yasuda N; Department of Orthopedic Surgery, Osaka National Hospital, Osaka, Japan., Nakai S; Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan., Nakai T; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Takenaka S; Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan., Okada S; Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.

Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Jul 03; Vol. 3 (7), pp. 1152-1165. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).